Sulfurous Acid

Sulfurous Acid

SCHEMBL3610180

O=CC=O.O=S([O-])O.O=S([O-])O.[Na+].[Na+]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Sulfurous Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA1 known ✓ P00915 1/20 0.36
CA2 known ✓ P00918 1/20 0.36
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfurous Acid SCHEMBL223079 1.00
Sulfurous Acid SCHEMBL7998800 1.00 ALDH1A1 (0.39) ALDH1A1CA1CA2
Sulfurous Acid SCHEMBL3409994 0.96 ALDH1A1 (0.36) ALDH1A1CA1CA2
Sulfurous Acid SCHEMBL5666129 0.96 ALDH1A1 (0.36) ALDH1A1CA1CA2
Sulfurous Acid SCHEMBL8428444 0.86 ALDH1A1 (0.33) ALDH1A1CA1CA2
Sulfurous Acid SCHEMBL29410199 0.83 CA1 (0.50) CA1CA2
Sulfurous Acid SCHEMBL889 0.83
Sulfurous Acid SCHEMBL1533868 0.83 CA1 (0.50) CA1CA2
Sulfurous Acid SCHEMBL453622 0.81
Sulfurous Acid SCHEMBL25405107 0.79 CA1 (0.46) CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4184929-A FORMALDEHYDE OR GLYOXAL, OR BISULFITE OR SULOXYLATE SALTS THEREOF AS EDUCING AGENTS OXY METAL INDUSTRIES CORPORATION (US) 1980-01-22 US claimed
US-20100094021-A1 NOVEL METHOD OF PREPARATION OF 5-CHLORO-3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOLE AND (3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOL-5YL)-DIALKYL-AMINES KALYPSYS, INC. (US) 2010-04-15 US disclosed
US-20080293942-A1 Methods of Preparing 2-Imidazol-1-Yl-4-Methyl-6-Pyrrolidin-2-Yl-Pyrimidine and 4-(1-Alkylpyrrolidin-2-Yl)-2-(1H-Imidazol-1-Yl)-6-Methylpyrimidine Derivatives COUSINS RUSSELL D 2008-11-27 US disclosed
EP-1954695-A1 NOVEL METHOD OF PREPARATION OF 5-CHLORO-3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOLE AND (3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOL-5-YL)-DIALKYL-AMINES Kalypsys, Inc. (US) 2008-08-13 EP disclosed
WO-2007062411-A1 NOVEL METHOD OF PREPARATION OF 5-CHLORO-3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOLE AND (3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOL-5-YL)-DIALKYL-AMINES KALYPSYS, INC. (US) 2007-05-31 WO disclosed
WO-2007062417-A1 METHODS OF PREPARING 2-IMIDAZOL-1-YL-4-METHYL-6-PYRROLIDIN-2-YL-PYRIMIDINE AND 4-(1-ALKYLPYRROLIDIN-2-YL)-2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDINE DERIVATIVES KALYPSYS, INC. (US) 2007-05-31 WO disclosed
US-20070123572-A1 NOVEL METHOD OF PREPARATION OF 5-CHLORO-3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOLE AND (3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOL-5YL)-DIALKYL-AMINES KALYPSYS, INC. (US) 2007-05-31 US disclosed
WO-2006119104-A2 PROCESS FOR PREPARING ISATINS WITH CONTROL OF SIDE-PRODUCT FORMATION WYETH (US) 2006-11-09 WO disclosed
US-20060247442-A1 Process for preparing isatins with control of side-product formation WYETH (US) 2006-11-02 US disclosed
EP-0735852-B1 LIQUID DISPENSER FOR STERILE SOLUTIONS BIOPOLYMERIX INC (US) 1999-09-22 EP disclosed
US-5869073-A APPLYING NON-LEACHABLE COATING ON SURFACE FROM SOLUTION, DISPERSION OR SUSPENSION OF A BIGUANIDE POLYMER REACTED WITH A CROSSLINKING AGENT TO FORM AN ADDUCT AND AN ANTIMICROBIAL METAL MATERIAL BIOPOLYMERIX, INC (GB) 1999-02-09 US disclosed
EP-0891712-A1 Liquid dispenser for sterile solutions BIOPOLYMERIX, INC. (US) 1999-01-20 EP disclosed
US-5681468-A POLYCATIONIC POLYMERIC MATERIAL AND METAL SALT BIOPOLYMERIX, INC. (US) 1997-10-28 US disclosed
EP-0735852-A1 LIQUID DISPENSER FOR STERILE SOLUTIONS BIOPOLYMERIX, INC. (US) 1996-10-09 EP disclosed
US-5490938-A HAVING FILTER COATED WITH BACTERIOSTATIC OR BACTERICIDAL SILVER CONTAINING MATERIAL BIOPOLYMERIX, INC. (US) 1996-02-13 US disclosed
WO-1995017152-A1 LIQUID DISPENSER FOR STERILE SOLUTIONS BIOPOLYMERIX, INC. (US) 1995-06-29 WO disclosed
US-4684483-A FROM GLYOXAL, AMINE, SULFUR DIOXIDE MONSANTO COMPANY (US) 1987-08-04 US disclosed
US-4184929-A FORMALDEHYDE OR GLYOXAL, OR BISULFITE OR SULOXYLATE SALTS THEREOF AS EDUCING AGENTS OXY METAL INDUSTRIES CORPORATION (US) 1980-01-22 US disclosed
US-4125402-A Method of processing silver dye bleaching materials and preparations suitable for the dye and silver bleaching CIBA-GEIGY AG (CH) 1978-11-14 US disclosed
US-4031232-A 1-Alkyl-2-(phenoxymethyl)-5-nitro-imidazoles and process for their manufacture HOECHST AKTIENGESELLSCHAFT (DT) 1977-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100094021-A1 NOVEL METHOD OF PREPARATION OF 5-CHLORO-3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOLE AND (3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOL-5YL)-DIALKYL-AMINES DCLK2, TH, DCLK3 CA1 4768/4885CA2 4473/4885ALDH1A1 1245/4885
US-20070123572-A1 NOVEL METHOD OF PREPARATION OF 5-CHLORO-3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOLE AND (3-IMIDAZOL-1-YL-[1,2,4]THIADIAZOL-5YL)-DIALKYL-AMINES DCLK2, TH, DCLK3 CA1 4768/4885CA2 4473/4885ALDH1A1 1245/4885
US-20060247442-A1 Process for preparing isatins with control of side-product formation NISCH, HASPIN, INMT CA1 1872/4885CA2 3776/4885ALDH1A1 1259/4885
US-20080293942-A1 Methods of Preparing 2-Imidazol-1-Yl-4-Methyl-6-Pyrrolidin-2-Yl-Pyrimidine and 4-(1-Alkylpyrrolidin-2-Yl)-2-(1H-Imidazol-1-Yl)-6-Methylpyrimidine Derivatives NOS2, NOS1, NOS3 CA1 4688/4885CA2 2213/4885ALDH1A1 1435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.